Abcellera doses first participants in a phase 1 clinical trial of abcl575

Vancouver, british columbia--(business wire)---- $abcl--abcellera doses first participants in a phase 1 clinical trial of abcl575.
ABCL Ratings Summary
ABCL Quant Ranking